English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

The CNS Myelin Proteome: Deep Profile and Persistence After Post-mortem Delay

MPS-Authors
/persons/resource/persons182214

Jahn,  O.
Proteomics, Wiss. Servicegruppen, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons270575

Siems,  S. B.
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182268

Kusch,  Kathrin
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182194

Hesse,  D.
Proteomics, Wiss. Servicegruppen, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons195523

Jung,  R. B.
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182277

Liepold,  T.
Proteomics, Wiss. Servicegruppen, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons192310

Uecker,  M.
Proteomics, Wiss. Servicegruppen, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons270577

Sun,  T.
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182481

Werner,  H. B.
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

3254176.pdf
(Publisher version), 4MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Jahn, O., Siems, S. B., Kusch, K., Hesse, D., Jung, R. B., Liepold, T., et al. (2020). The CNS Myelin Proteome: Deep Profile and Persistence After Post-mortem Delay. Frontiers in Cellular Neuroscience, 14: 249. doi:10.3389/fncel.2020.00239.


Cite as: https://hdl.handle.net/21.11116/0000-0007-1208-C
Abstract
Myelin membranes are dominated by lipids while the complexity of their protein
composition has long been considered to be low. However, numerous additional myelin
proteins have been identified since. Here we revisit the proteome of myelin biochemically
purified from the brains of healthy c56Bl/6N-mice utilizing complementary proteomic
approaches for deep qualitative and quantitative coverage. By gel-free, label-free mass
spectrometry, the most abundant myelin proteins PLP, MBP, CNP, and MOG constitute
38, 30, 5, and 1% of the total myelin protein, respectively. The relative abundance of
myelin proteins displays a dynamic range of over four orders of magnitude, implying
that PLP and MBP have overshadowed less abundant myelin constituents in initial
gel-based approaches. By comparisons with published datasets we evaluate to which
degree the CNS myelin proteome correlates with the mRNA and protein abundance
profiles of myelin and oligodendrocytes. Notably, the myelin proteome displays only
minor changes if assessed after a post-mortem delay of 6 h. These data provide the
most comprehensive proteome resource of CNS myelin so far and a basis for addressing
proteomic heterogeneity of myelin in mouse models and human patients with white
matter disorders.